Exploring advances, evaluating what remains to be done
Search results for: allopurinol
Aggressive Urate Lowering Needed for Gout
Patients with gout at increased risk for cardiovascular disease and adverse event
Letters to the Editor: In Memoriam
One more prescribing rule [See “Rheuminations,” September 2009, p. 6], honored mainly in the breach, in our overspending climate: don’t prescribe an expensive brand when generics are as good or better, especially Nexium (which I have never prescribed) versus omeprazole, Lipitor versus simvastatin (which now costs the VA three cents a pill), and—for rheumatologists who are writing 80% Uloric—allopurinol except for the 10% who might need Uloric.
Reading Rheum
Handpicked Reviews of Contemporary Literature
Risks and Benefits
Physicians must find the delicate balance between treatment and side effects
Letters
Feedback From Our Readers
Quality Advice from Specialty Societies
The ACR’s Quality Stakeholders’ Summit explored quality initiatives from several medical societies
Difficult Gout
“Grandpapa’s Torments” was the Rodnan Commemorative Gout Print featured at the 2005 ACR/ARHP Annual Scientific Meeting.
- « Previous Page
- 1
- …
- 10
- 11
- 12